| 结节性淋巴细胞为主型霍奇金淋巴瘤七例 |
| |
| 引用本文： | 黄潞,黄韵红.结节性淋巴细胞为主型霍奇金淋巴瘤七例[J].白血病．淋巴瘤,2010,19(7):618-619. |
| |
| 作者姓名： | 黄潞 黄韵红 |
| |
| 作者单位： | 贵州省肿瘤医院血液淋巴瘤科,贵阳,550000; |
| |
| 摘 要： | 目的 探讨结节性淋巴细胞为主型霍奇金淋巴瘤(NLPHL)临床病理特征及治疗.方法 经病理免疫组织化学证实为NLPHL患者7例.6例患者接受化疗和受累野放疗的综合治疗;1例仅接受单纯化疗.结果 3年局部控制率和总生存率分别为100%和86%.1例患者死于化疗后肺部感染.结论 NLPHL预后良好,综合治疗耐受好,不良反应少,但应注意治疗后不良反应的处理.
|
| 关 键 词： | 结节性淋巴细胞霍奇金淋巴瘤 诊断 治疗 |
7 cases of nodular lymphocyte-predominant Hodgkin lymphoma |
| |
| HUANG Lu,HUANG Yun-hong.7 cases of nodular lymphocyte-predominant Hodgkin lymphoma[J].Journal of Leukemia & Lymphoma,2010,19(7):618-619. |
| |
| Authors: | HUANG Lu HUANG Yun-hong |
| |
| Abstract: | Objective To investigate the clinicopathological characteristics and treatment of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Methods Seven patients were confirmed as NLPHL by pathologic immunohistochemistry. Six patients received combined-modality therapy of chemotherapy and involved field, and the other one received single chemotherapy. Results The 3-year local control rate and overall survival rate were 100 % and 86 %, respectively. Only one case died of pulmonary infection following chemotherapy. Conclusion These patients with NLPHL has favorable prognosis, tolerance and less toxicity for combined-modality therapy. However the management of toxicity following treatment should be noted. |
| |
| Keywords: | Nodular lymphocyte-predominant Hodgkin lymphomaDiagnosisTherapy |
|
|
